Moving Toward Total Therapy in AML: Personalized Treatments Improve Post-Transplant Outcome

J Clin Oncol. 2024 May 20;42(15):1731-1733. doi: 10.1200/JCO.24.00006. Epub 2024 Mar 12.

Authors

Naval G Daver¹, Charles Craddock²

Affiliations

¹ Department of Leukemia, MD Anderson Cancer Centre, Houston, TX.
² Warwick Clinical Trials Unit, University of Warwick, Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom.

PMID: 38471058
DOI: 10.1200/JCO.24.00006

No abstract available

Publication types

Editorial

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
Leukemia, Myeloid, Acute* / mortality
Leukemia, Myeloid, Acute* / therapy
Precision Medicine*
Treatment Outcome